Cargando…
Forkhead Box M1 Transcription Factor Drives Liver Inflammation Linking to Hepatocarcinogenesis in Mice
BACKGROUND & AIMS: Liver inflammation has been recognized as a hallmark of hepatocarcinogenesis. Although Forkhead Box M1 (FoxM1) is a well-defined oncogenic transcription factor that is overexpressed in hepatocellular carcinoma (HCC), its role in liver inflammation has never been explored. METH...
Autores principales: | Kurahashi, Tomohide, Yoshida, Yuichi, Ogura, Satoshi, Egawa, Mayumi, Furuta, Kunimaro, Hikita, Hayato, Kodama, Takahiro, Sakamori, Ryotaro, Kiso, Shinichi, Kamada, Yoshihiro, Wang, I-Ching, Eguchi, Hidetoshi, Morii, Eiichi, Doki, Yuichiro, Mori, Masaki, Kalinichenko, Vladimir V., Tatsumi, Tomohide, Takehara, Tetsuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016284/ https://www.ncbi.nlm.nih.gov/pubmed/31669262 http://dx.doi.org/10.1016/j.jcmgh.2019.10.008 |
Ejemplares similares
-
Targeting the mevalonate pathway is a novel therapeutic approach to inhibit oncogenic FoxM1 transcription factor in human hepatocellular carcinoma
por: Ogura, Satoshi, et al.
Publicado: (2018) -
CEACAM1 Is Associated With the Suppression of Natural Killer Cell Function in Patients With Chronic Hepatitis C
por: Suda, Takahiro, et al.
Publicado: (2018) -
Increased Bcl-xL Expression in Pancreatic Neoplasia Promotes Carcinogenesis by Inhibiting Senescence and Apoptosis
por: Ikezawa, Kenji, et al.
Publicado: (2017) -
CRISPR Loss-of-Function Screen Identifies the Hippo Signaling Pathway as the Mediator of Regorafenib Efficacy in Hepatocellular Carcinoma
por: Suemura, Shigeki, et al.
Publicado: (2019) -
Improvement of Skeletal Muscle Mass after Ledipasvir and Sofosbuvir Treatment for Hepatitis C Virus in Decompensated Liver Cirrhosis
por: Sakamori, Ryotaro, et al.
Publicado: (2021)